Androgen Deprivation Therapy trials for Prostate cancer

All Androgen Deprivation Therapy trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Androgen Deprivation Therapy for Prostate cancer

• A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
  NCT05726292 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
  NCT04916613 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 95 locations
• APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate Cancer
  NCT06709326 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 81 Years · Sex: Male · 1 location
• Implementation of Precision Medicine in High-risk Prostate Cancer
  NCT06687421 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
  NCT04983095 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 7 locations
• Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
  NCT05352178 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location
• PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
  NCT06274047 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 6 locations
• PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
  NCT06392295 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Pembro With Radiation With or Without Olaparib
  NCT05568550 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging
  NCT06276465 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 4 locations
• Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life
  NCT06171269 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials study Androgen Deprivation Therapy for Prostate cancer?

11 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.